TET2 and neoplasm: Results revealed that repeated stimulation with CD19+ tumor cells allowed continual expansion of TET2 knockdown CAR T‐cells in an antigen‐dependent manner, whereas this same re‐stimulation in CAR T‐cells with wildtype TET2 resulted in complete arrest of cell growth.